Search

Supplemental material, sj-docx-1-phr-10.1177_00333549231155472 for Perceived Benefits and Barriers of a COVID-19 Test to Stay Program in a School District Serving Black or African American People With Low Income, December 2021 by Emiko Kamitani, Emily J. Holman, David Philpott, Vidisha D. Parasram, Laird J. Ruth, Chisom Onyeuku, Brittani Carter, Eugenia Gwynn, Timothy W. Beck, Kelly Regan, LaVerne R. Hagler, Angela Clark, Gene Shelley and Ebony S. Thomas in Public Health Reports

Repeating the BinaxNOW antigen test for SARS-CoV-2 by two groups of readers within 30 minutes resulted in high concordance (98.9%) in 2,110 encounters. BinaxNOW test sensitivity was 77.2% (258/334) compared to real-time reverse transcription-polymerase chain reaction. Same day antigen testing did not significantly improve test sensitivity while specificity remained high.

Supplemental material, sj-docx-1-hpp-10.1177_15248399211038364 for Health Care Providers’ Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis by Yuko Mizuno, Deborah J. Gelaude, Nicole Crepaz, Emiko Kamitani, Julia B. DeLuca, Carolyn A. Leighton, Megan E. Wichser and Dawn K. Smith in Health Promotion Practice

Background: Asian Pacific Islander is the only racial group which significantly increased in estimated annual percentage of HIV newly diagnosed individuals between 2001-2008. As rates of HIV infection rise in the Asians population, it is important for us to increase our understanding about what facilitates HIV infection in this population and to focus on decreasing HIV related morbidity and mortality. Stigma, an important concept in the field of international HIV research, is increasingly being associated with access to prevention, care, and treatment outcomes in the population of people living with HIV in the US. Objective: The purposes of my dissertation study were: (1) to report on the steps taken to develop a HIV stigma scale that are relevant for Asians living with HIV (ALH) and test the psychometric properties of the scale; (2) to assess the level of stigma experienced by ALH by using the scale and explore the association to the acculturation and self-rated general health in a sample of ALH; and (3) to explore the level of knowledge, attitudes, and self-perceived risk of cardiovascular disease (CVD) and acute coronary syndrome (ACS) in a sample of ALH and how these factors are influenced by the stigma.Methods: This study used a convenience sample comprised 83 ALH from November 2010 to June 2013 (n=5 in face-to-face interviews, n=11 in focus groups, and n=67 in cross-sectional study). Results: This study developed the first HIV stigma scale culturally adapted to ALH and found the HIV stigma was often experienced by ALH and negatively associated to acculturation and health outcomes. Also, the study sample had limited knowledge of, positive attitude toward, and low self-perceived risk regarding CVD and ACS. HIV stigmatization was independently correlated with attitude; acculturation was an independent predictor of level of knowledge. Conclusions: Such a high level of HIV stigma experienced by ALH, poor knowledge, positive attitude, and low self-perceived risk of CVD and ACS are matters of concern. Since HIV stigma is negatively associated to acculturation, health outcomes and attitude toward CVD and ACS, we need for culturally-appropriate interventions to reduce HIV stigma experienced by ALH.